USD 45+ Bn Global Microfluidics Market is Expected to Grow at a CAGR of over 15.90% During 2022-2028 | Vantage Market Research


WASHINGTON, April 22, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Microfluidics Market finds that the increase in demand for point-of-care diagnostics is expediting market growth. Primarily driven by rising private investments and venture funding for the development of new products, the total Global Microfluidics Market is estimated to reach USD 45.15 Billion by the year 2028.

The Global Market valued at USD 18.62 Billion in the year 2021, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 15.90%.

Furthermore, increasing government support is also anticipated to augment the growth of the Global Microfluidics Market, states Vantage Market Research, in a report, titled “Microfluidics Market Size, Share & Trends Analysis Report by Technology (PCR & RT-PCR, Gel Electrophoresis, Microarrays, ELISA), by Application (Lab-on-a-chip, Organs-on-chips, Continuous Flow Microfluidics, Optofluidics and Microfluidics), by End User (Hospitals & Diagnostic Centres, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)”.

Market Dynamics:

Increase in Demand for Point-of-care Diagnostics to Fuel Global Microfluidics Market

The increase in demand for point-of-care diagnostics is expected to fuel the growth of the Microfluidics Market during the forecast period. This is attributable to the rising prevalence of infectious diseases along with the growing preference for home healthcare. Point-of-care testing is considered to be a sensational innovation in the field of diagnosis. Microfluidic based point-of-care testing provides prompt results and also improves disease detection and diagnosis with the help of small sample volumes. Even though the accuracy and sensitivity of POCT is still arguable as compared to conventional lab-based testing, the COVID-19 pandemic put emphasis on the need for more rapid testing platforms. It will be fascinating to see how future scientific and technological advances will bridge this gap, and whether POCT will genuinely become the go-to for illness diagnosis. Further, the rising incidences of various diseases, coupled with product miniaturization and decentralization of healthcare are also expected to offer significant growth opportunities to players operating in the market.

Please Check Out Our Free Sample Reports and Make a More Informed Decision:

Get Access to a Free Copy of Our Latest Sample Report @ https://www.vantagemarketresearch.com/microfluidics-market-1485/request-sample

(Sample reports are a great way to test our in-depth reports or study before you make a purchase)

  • The newly updated, 140+ page reports provide an in-depth analysis of the COVID-19 virus and pandemic.
  • Using industry data and interview with experts, you can learn about topics such as regional impact analysis, global forecast, competitive landscape analysis, size & share of regional markets.
  • We offer these reports in PDF format so you can read them on your computer and print them out.
  • Free sample includes, Industry Operating Conditions, Industry Market Size, Profitability Analysis, SWOT Analysis, Industry Major Players, Historical and Forecast, Growth Porter's 5 Forces Analysis, Revenue Forecasts, Industry Trends, Industry Financial Ratios.
  • The report also presents the country-wise and region-wise analysis of the Vantage Market Research and includes a detailed analysis of the key factors affecting the growth of the market.
  • Sample Report further sheds light on the Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis, to offer the readers an advantage over others.

Key Insights & Findings from the Report:

  • According to our primary respondents’ research, the Microfluidics market is predicted to grow at a CAGR of roughly 15.90% during the forecast period.
  • The Microfluidics market was estimated to be worth roughly USD 18.62 Billion in 2021 and is expected to reach USD 45.15 Billion by 2028; based on primary research.
  • On the basis of region, Asia Pacific is projected to dominate the worldwide Microfluidics market.

Purchase This Premium Report Now @ https://www.vantagemarketresearch.com/buy-now/microfluidics-market-1485/0

Benefits of Purchasing Microfluidics Market Reports:

  • Customer Satisfaction: Our team of experts assists you with all your research needs and optimizes your reports.
  • Analyst Support: Before or after purchasing the report, ask a professional analyst to address your questions.
  • Assured Quality: Focuses on accuracy and quality of reports.
  • Incomparable Skills: Analysts provide in-depth insights into reports.

Segmentation of Global Microfluidics Market:

  • Technology
    • PCR & RT-PCR
    • Gel Electrophoresis
    • Microarrays
    • ELISA
    • Non-Medical Technologies
  • Application
    • Lab-on-a-chip
    • Organs-on-chips
    • Continuous Flow Microfluidics
    • Optofluidics and Microfluidics
    • Acoustofluidics and Microfluidics
    • Electrophoresis and Microfluidics
  • End User
    • Hospitals & Diagnostic Centers
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
  • Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Read Full Research Report @ https://www.vantagemarketresearch.com/industry-report/microfluidics-market-1485

Growing Private Investments and Venture Funding to Augment Market Growth

The increasing private investments and venture funding for the development of new products, coupled with government support is anticipated to augment the growth of the Microfluidics Market within the estimated period. For instance, the Indian government is expected to introduce a credit incentive programme worth Rs. 500 billion in order to boost the infrastructure of the country’s healthcare sector. This will further allow firms to leverage the fund to expand their hospital capacity and supplies with the government acting as a guarantor and strengthen COVID-19-related health infrastructure in smaller towns. However, the complex and time-consuming regulatory approval process along with incorporation of microfluidics into existing workflows is expected to hamper the growth of the market in near future. Moreover, the emergence of microfluidic-based 3D cell culture systems along with expanding applications of drug delivery technologies using microfluidics is further expected to open new market avenues within the estimated time period.

COVID-19 Impact Analysis:

The COVID-19 outbreak has affected various industries worldwide. Governments across the world implemented strict lockdown measures and social distancing norms in order to restrict the swift spread of the pandemic. Manufacturing facilities around the world were shut down during the initial stages of the pandemic. Moreover, the economic crisis after the pandemic might lead to a significant delay in the commercial roll-out of the healthcare industry. Small and medium-scale companies are the backbone of technology providers and are witnessing a steep drop in revenue since the emergence of the pandemic in 2020. Hence, market players faced numerous challenges as disruptions in the supply chain were observed. However, things will improve in the second half of 2022 as more supplies will come online. The impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends of the market for all the regions and countries based on the following data points:

  1. Impact Assessment of COVID-19 Pandemic
    1. North America
    2. Europe
    3. Asia Pacific
    4. Latin America
    5. Middle East & Africa
  2. Quarterly Market Revenue Forecast by Asia Pacific 2020 & 2021
  3. Key Strategies Undertaken by Companies to Tackle COVID-19
  4. Long Term Dynamics
  5. Short Term Dynamics

Do You Have Any Query or Specific Requirement? Ask to Our Industry Expert@ https://www.vantagemarketresearch.com/microfluidics-market-1485/inquiry-before-buying

(You may enquire a report quote OR available discount offers to our sales team before purchase.)

The report on Microfluidics Market highlights:

● Assessment of the market

● Premium Insights

● Competitive Landscape

● COVID Impact Analysis

● Historic Data, Estimates and Forecast

● Company Profiles

● Global and Regional Dynamics

Regional Analysis:

North America to Dominate the Global Microfluidics Market

North America has dominated the Global Microfluidics Market in 2021 and is likely to continue the same trend during the forecast period. The United States dominated North America in 2021. This is attributable to the development of novel microfluidic devices in the region along with increasing investments in the healthcare industry. Furthermore, the presence of well-established players and emerging companies that are engaged in manufacturing microfluidics products in the region are also anticipated to fuel the growth of the market in the region. Asia-Pacific is expected to grow at a considerable Compound Annual Growth Rate (CAGR) during the forecast period. This is attributable to the increase in government support for advanced infrastructure. The ever-increasing need for healthcare services is also expected to support regional growth of the market.

List of Prominent Players in the Microfluidics Market:

  • Parker Hannifin Corporation (US)
  • SMC Corporation (Japan)
  • IDEXX Corporation (US)
  • Fluigent SA (France)
  • Aignep S.P.A. (Italy)
  • Camozzi Automation SPA Societá Unipersonale (Italy)
  • Dolomite microfluidics (UK)
  • Elveflow (France)
  • Cellix Limited (Ireland)
  • Fortive Corporation (US)
  • Danaher Corporation (US)
  • Thermo Fisher Scientific Inc. (US)
  • Perkinelmer Inc. (US)
  • Agilent Technologies Inc. (US)
  • Bio-Rad Laboratories Inc. (US)
  • Becton
  • Dickinson and Company (US)
  • Illumina Inc. (US)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Fluidigm Corporation (US)
  • Abbott Laboratories (US)

Browse market data Tables and Figures spread through 144 Pages and in-depth TOC on "Microfluidics Market Size, Share & Trends Analysis Report by Technology (PCR & RT-PCR, Gel Electrophoresis, Microarrays, ELISA), by Application (Lab-on-a-chip, Organs-on-chips, Continuous Flow Microfluidics, Optofluidics and Microfluidics), by End User (Hospitals & Diagnostic Centers, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)" View detailed Research Report here - https://www.vantagemarketresearch.com/press-release/microfluidics-market-618645

Recent Developments:

March, 2022: Miroculus, Inc., announced the formal launch of the Miro Canvas, a compact, easy-to-use digital microfluidics platform that enables on-demand automation of complex next-generation sequencing (NGS) sample preparation protocols.

Key questions answered in the report:

  • Which regional market will show the highest and rapid growth?
  • Which are the top five players of the Microfluidics Market?
  • How will the Microfluidics Market change in the upcoming six years?
  • Which application and product will take a lion’s share of the Microfluidics Market?
  • What is the Microfluidics market drivers and restrictions?
  • What will be the CAGR and size of the Microfluidics Market throughout the forecast period?           

This market titled “Microfluidics Market” will cover exclusive information in terms of Regional Analysis, Forecast, and Quantitative Data – Units, Key Market Trends, and various others as mentioned below:

ParameterDetails
Market Size Provided for Years2016-2028
Base Year2021
Historic Years2016-2020
Forecast Years2022-2028
Segments Covered
  • Technology
    • PCR & RT-PCR
    • Gel Electrophoresis
    • Microarrays
    • ELISA
    • Non-Medical Technologies
  • Application
    • Lab-on-a-chip
    • Organs-on-chips
    • Continuous Flow Microfluidics
    • Optofluidics and Microfluidics
    • Acoustofluidics and Microfluidics
    • Electrophoresis and Microfluidics
  • End User
    • Hospitals & Diagnostic Centers
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
  • Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
Region & Counties Covered
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • U.K
    • France
    • Germany
    • Italy
    • Spain
    • Rest Of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South East Asia
    • Rest Of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest Of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest Of Middle East & Africa
Companies Covered
  • Parker Hannifin Corporation (US)
  • SMC Corporation (Japan)
  • IDEXX Corporation (US)
  • Fluigent SA (France)
  • Aignep S.P.A. (Italy)
  • Camozzi Automation SPA Societá Unipersonale (Italy)
  • Dolomite microfluidics (UK)
  • Elveflow (France)
  • Cellix Limited (Ireland)
  • Fortive Corporation (US)
  • Danaher Corporation (US)
  • Thermo Fisher Scientific Inc. (US)
  • Perkinelmer Inc. (US)
  • Agilent Technologies Inc. (US)
  • Bio-Rad Laboratories Inc. (US)
  • Becton
  • Dickinson and Company (US)
  • Illumina Inc. (US)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Fluidigm Corporation (US)
  • Abbott Laboratories (US).
Report CoverageMarket growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis

Customization of the Report:

The report can be customized as per client needs or requirements. For any queries, you can contact us on sales@vantagemarketresearch.com or +1 (202) 380-9727. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.

Download Free Sample Report Now @ https://www.vantagemarketresearch.com/microfluidics-market-1485/request-sample

Browse More Related Report:

About Vantage Market Research:

We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.

Follow Us on LinkedIn: https://www.linkedin.com/company/vantage-market-research/

Follow Us on Twitter: https://twitter.com/vantagemarketr

Contact us

Eric Kunz

6218 Georgia Avenue NW Ste 1 - 564

Washington DC 20011-5125

United States Tel: +1 202 380 9727

Email: sales@vantagemarketresearch.com

Website: https://www.vantagemarketresearch.com/

Latest Vantage Market Research Press Releases @ https://www.vantagemarketresearch.com/insight/press-releases

Latest Vantage Market Research Blog @ https://www.vantagemarketresearch.com/insight/blogs

Blog: